Crenshaw’s exit leaves the SEC without Democratic representation as the agency and other US financial regulators face leadership gaps.
You might also be interested in reading Milestone Pharmaceuticals GAAP EPS of -$0.20 misses by $0.02.
Crenshaw’s exit leaves the SEC without Democratic representation as the agency and other US financial regulators face leadership gaps.
You might also be interested in reading Milestone Pharmaceuticals GAAP EPS of -$0.20 misses by $0.02.